1-9 of 9
Katharine Batt
Close
Sort by
Journal Articles

Systematic Literature Review (SLR) of Fatigue in Patients with Sickle Cell Disease (SCD) As Measured By the Patient-Reported Outcomes Measurement Information System (PROMIS Fatigue)

Katharine Batt, Kit Albrecht, Sam Wilson, Ruth du Moulin
Journal: Blood
Blood (2023) 142 (Supplement 1): 7320.
https://doi.org/10.1182/blood-2023-188376
Published: 2023
Journal Articles

A Real-World Study of Pre-Post Annualized Bleed Rates and All Cause Costs Among Non-Inhibitor Patients with Hemophilia a Switching from FVIII Prophylaxis to Emicizumab

Katharine Batt, Bob G Schultz, Jorge Caicedo, Christopher S Hollenbeak, Neha Agrawal, Sagnik Chatterjee, Megha Dayma, Michael Bullano
Journal: Blood
Blood (2021) 138 (Supplement 1): 3028.
https://doi.org/10.1182/blood-2021-146616
Published: 2021
Journal Articles

Lung Function Monitoring in Allogenic Hematopoietic Cell Transplant (A-HCT) Patients

Naomi C Sacks, PhD, Bridget Healey, MPH, Sajjad Raza, PhD MD, Yanmei Liu, MS, Philip Cyr, MPH, Katharine Batt, MD MSc, Gerhard Boerner, PhD, Dario Cuomo, MD, Ajay Sheshadri, MD MSCI
Journal: Blood
Blood (2020) 136 (Supplement 1): 8.
https://doi.org/10.1182/blood-2020-134181
Published: 2020
Journal Articles

Quantifying the Economic Burden of Myelodysplastic Syndromes Among Elderly US Patients

Jason Shafrin, PhD, Sarah Green, BA, Richard Murphy, BA, Katie Everson, MS, Syvart Dennen, M.Phil, Kwanza Price, MPH, Katharine Batt, MD MSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 2151.
https://doi.org/10.1182/blood-2019-124216
Published: 2019
Journal Articles

Economic Burden of Bronchiolitis Obliterans Syndrome (BOS) Following Allogeneic Hematopoietic Stem Cell Transplant (alloHSCT) in Patients with Commercial Insurance in the United States

Naomi Sacks, PhD, Bridget Healey, MPH, Philip Cyr, MPH, Katharine Batt, MD MSc, Noreen Roth Henig, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3410.
https://doi.org/10.1182/blood-2019-127197
Published: 2019
Journal Articles

The Economic Value of CTL019 Therapy for Pediatric Patients with Relapsed and Refractory Acute Lymphoblastic Leukemia in the United Kingdom

Julia Snider, PhD, Michelle Brauer, BS, Yanni Hao, PhD, Pinar Karaca-Mandic, PhD, Mahlet Gizaw Tebeka, MS, Jie Zhang, PhD, Katharine Batt, MD MSc
Journal: Blood
Blood (2017) 130 (Supplement 1): 1330.
https://doi.org/10.1182/blood.V130.Suppl_1.1330.1330
Published: 2017
Journal Articles

Linear and Logistic Regression Models of Patient-Reported Outcomes and Patient Characteristics in US Adults with Hemophilia from the Pain, Functional Impairment, and Quality of Life (P-FiQ) Study

Katharine Batt, MD MSc, Michael Recht, MD PhD, Michael Wang, MD, Doris V. Quon, MD PhD, Lisa N Boggio, MD MS, Craig M. Kessler, MD, Tyler W. Buckner, MD MSc, Anne T. Neff, MD, Neeraj N Iyer, PhD, David L Cooper, MD MBA, Christine L Kempton, MD MSc
Journal: Blood
Blood (2016) 128 (22): 252.
https://doi.org/10.1182/blood.V128.22.252.252
Published: 2016
Journal Articles

Economic Impact of Disease Progression in Medicare Patients with Relapsed Multiple Myeloma

Joanna P. MacEwan, PhD, Katharine Batt, MD MSc, Wes Yin, PhD, Desi Peneva, MS, Steve Sison, MS, Seanna Vine, MS, Manan Shah, PhD, Clara Chen, PhD MS
Journal: Blood
Blood (2015) 126 (23): 2116.
https://doi.org/10.1182/blood.V126.23.2116.2116
Published: 2015
Journal Articles

Assessing the Economic Burden in Medicare Patients with Multiple Myeloma

Joanna P. MacEwan, PhD, Katharine Batt, MD MSc, Wes Yin, PhD, Desi Peneva, MS, Steve Sison, MS, Seanna Vine, MS, Manan Shah, PhD, Clara Chen, PhD MS
Journal: Blood
Blood (2015) 126 (23): 2100.
https://doi.org/10.1182/blood.V126.23.2100.2100
Published: 2015